Next Article in Journal / Special Issue
Thia-Michael Reaction under Heterogeneous Catalysis
Previous Article in Journal
Synthesis and Wittig Rearrangement of 3- and 4-Benzyloxyphenylphosphonamidates
Previous Article in Special Issue
Parallel Synthesis of Aurones Using a Homogeneous Scavenger
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Organics
Volume 4
Issue 1
10.3390/org4010006
organics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Palladium Catalyzed Ring-Opening of Diazabicylic Olefins with 4-Halo-1,3-Dicarbonyl Compounds: Accessing 3(2H)-Furanone-Appended Cyclopentenes

by
Vishnu K. Omanakuttan
1,2,
Alisha Valsan
1,2,
Henning Hopf
3,* and
Jubi John
1,2,*
1
Chemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram 695019, India
2
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
3
Institut für Organische Chemie, Technische Universität Braunschweig, Hagenring 30, D-38106 Braunschweig, Germany
*
Authors to whom correspondence should be addressed.
Organics 2023, 4(1), 70-85; https://doi.org/10.3390/org4010006
Submission received: 19 December 2022 / Revised: 10 January 2023 / Accepted: 7 February 2023 / Published: 13 February 2023
(This article belongs to the Collection Advanced Research Papers in Organics)
Browse Figures
Versions Notes

Abstract

:
We have realized a Pd-catalyzed ring-opening of diazabicyclic olefins with 4-halo-1,3-dicarbonyl compounds. This reaction resulted in the formation of 3(2H)-furanone-appended hydrazino cyclopentenes. The reaction proceeds via the formation of a π-allylpalladium intermediate which is attacked by the active methylene species, and an intramolecular nucleophilic substitution in the 4-halo-1,3-dicarbonyl moiety furnishes the 3(2H)-furanone-substituted cyclopentene. We could extend this methodology to cyclopropane-appended spirotricyclic olefin for synthesizing 3(2H)-furanone-substituted spiro[2.4]hept-5-ene.

1. Introduction

Among oxygen-containing heterocyclic compounds, furanones [1,2,3,4] compose an important subclass, as it constitutes the pharmacophores of many biologically active molecules (both natural and synthetic), which covers various therapeutic categories, viz. analgesic, anti-inflammatory, anticancer, anticonvulsant, antibacterial, antifungal, antioxidant, antiulcer, anti-tuberculosis etc. [5]. Among the different furanones, namely (i) 2(3H)-furanone, (ii) 2(5H)-furanones, and (iii) 3(2H)-furanone, the later occupies a salient position because of its broad range of biological activities [6,7,8]. In past decades, significant attention was laid on devising synthetic routes towards substituted 3(2H)-furanone moieties with the ultimate aim of synthesizing natural products incorporating this heterocycle [9,10]. Different synthetic protocols for the preparation of this heterocyclic compound were reported, which included acid or base mediated, Lewis acid or base catalyzed, organocatalytic and transition-metal catalyzed transformations. In 2012, the groups of Lu and Yan independently reported the organocatalytic reaction of 4-bromoacetoacetate with nitrostyrene towards the synthesis of 4,5-disubstituted-3(2H)-furanones, and Yu reported an asymmetric synthesis of succinimide substituted 3(2H)-furanones (Figure 1) [11,12,13]. Soon after, our group also reported the reactions of 4-halo-1,3-dicarbonyl compounds with different electrophilic species such as activated alkene, activated imine, dialkylazodicarboxylates and arynes to access various 4,5-disubstituted-3(2H)-furanone derivatives (Figure 1) [14,15,16,17]. There is still immense scope for exploring the reactivity of 4-halo-1,3-dicarbonyl compounds with unexplored electrophiles for generating new scaffolds.
Diazabicyclic olefins are meso-compounds with multiple points of fracture, which upon clever ring-opening strategies can lead to highly functionalized/fused cyclopentanoids [18,19,20,21]. These heterobicyclic olefins can be easily synthesized in large quantities by the Diels Alder cycloaddition between cyclopentadiene and dialkylazodicarboxylate. The unique reactivity of these heterobicyclic olefins can be attributed to the ring strain that enables facile skeletal rearrangements under mild conditions. The initial attempts of desymmetrization involved hydroformylation, hydroboration, hydroarylation and dihydroxylation, all without ring opening of the bicyclic structure [22,23,24,25,26,27]. Mono-centered reactive species such as organometallic reagents and organic halides were later used for the ring opening of diazabicyclic olefins towards functionalized cyclopentenes [28,29,30,31,32,33,34,35,36,37]. Methodologies for cyclopentannulation with diazabicyclic olefins were then introduced by utilizing different bi-centered reactive species such as 2-iodophenol/aniline, salicylaldehyde, aryl enamides and 3-methyl 2-iodobenzoate [38,39,40,41,42]. In 2003, Micouin and co-workers reported the use of nucleophiles such as phenol and active methylene compounds for trapping the π-allyl palladium species generated from diazabicyclic olefin under Pd-catalysis (Figure 2a) [43]. Later, the same reactivity was extended by Radhakrishnan and co-workers to fulvene derived diazabicyclic olefins and to cyclopropane-appended spirotricyclic olefins to generate 1,4-disubstituted alkylidenecyclopentenes and cis-4,7-disubstituted spiro[2.4]hept-5-ene respectively [44,45]. Based on these literature reports, we hypothesized that 4-halo-1,3-dicarbonyl compounds could be used for trapping the π-allyl palladium intermediate generated from diazabicyclic olefins in the presence of Pd-catalyst for accessing 3(2H)-furanone-appended hydrazino cyclopentenes (Figure 2b).

2. Results and Discussion

We planned to assess our hypothesis by taking diazabicyclic olefin 1a and ethyl-4-chloro acetoacetate 2a as substrates. The initial reaction was set up with 1.0 equivalent of 1a and 1.5 equivalents of 2a in the presence of Pd(OAc)2 as the catalyst, dppf as ligand and K2CO3 as base in THF at 60 °C. After 12 h, we could isolate the expected 3(2H)-furanone-appended hydrazino cyclopentene 3a in 10% yield from the reaction mixture (Figure 3). The structure of 3a was assigned based on 1H NMR, 13C NMR, high resolution mass spectral analyses and on comparison with literature reports [43,44,45].
In the HMBC spectrum of 3a (spectrum in SI), the proton signal at 3.40–3.42 ppm (1′) showed correlations with C5, C4 and C3 carbons (Figure 4). These relations confirmed the connectivity of cyclopentene moiety with 3(2H)-furanone core. The cis stereochemistry at the 1′ and 4′ positions was confirmed through the NOE analysis (spectrum in SI) and in comparison with the literature reports [43,44,45]. When we irradiated the signal at 3.40–3.42 ppm, a signal enhancement in the opposite phase was observed at 5.32 ppm. This confirmed the stereochemistry of protons at 3.40–3.42 and 5.32 ppm as in the same phase.
The optimization of the Pd-catalyzed ring opening of diazabicyclic olefin with 4-halo-1,3-dicarbonyl compounds was carried out with 1a and 2a as substrates. We started with the screening of Pd-catalysts such as Pd(OAc)2, Pd(OCOCF3)2, Pd(PPh3)4, (Pd(allyl)Cl)2, PdCl2 and Pd(dba)3.CHCl3 among which the (Pd(allyl)Cl)2 catalyzed reaction afforded the 3(2H)-furanone-appended hydrazino cyclopentene 3a in 32% yield (Table 1, entries 1–6). We then checked the efficiency of different ligands like dppf, dppe, dppp, XPhos and DevPhos, from which XPhos was found to be the best option (Table 1, entries 4, 7–10). A base screen revealed that K2CO3 was superior to other bases like Na2CO3, Cs2CO3, NaH and NaOtBu (Table 1, entries 9, 11–14). Finally, we examined different solvents such as THF, CH3CN, toluene, 1,4-dioxane and DCE among which 3a was isolated in 85% yield from the reaction with DCE as the medium (Table 1, entries 9, 15–18).
The optimized conditions for the Pd-catalyzed synthesis of 3(2H)-furanone-appended hydrazino cyclopentene was found to be 1.0 equivalent of diazabicyclic olefin 1, 1.5 equivalents of 4-halo-1,3-dicarbonyl compound 2, 2.0 equivalents of K2CO3, 5 mol% of (Pd(allyl)Cl)2, 10 mol% of XPhos in DCE (solvent) at 60 °C for 12 h. Under these conditions, the generality of the 3(2H)-furanone-appended 3,5-disubstituted cyclopentene synthesis was studied with different diazabicyclic olefins and of 4-halo-1,3-dicarbonyl compounds (Figure 5). The reactions of diazabicyclic adduct 1a with ethyl-4-chloro acetoacetate 2a and methyl-4-chloro acetoacetate 2b afforded the corresponding products 3a and 3b in 85% and 88% yields, respectively. In a similar way, the reactions of bicyclic adduct 1b (derived from cyclopentadiene and diisopropylazodicarboxylate) with 2a and 2b furnished the products 3c and 3d in excellent yields. There was a decrease in yield for 3(2H)-furanone-appended hydrazino cyclopentenes 3e (57%), 3f (64%), 3g (64%) and 3h (75%) synthesized from bicyclic adducts 1c and 1d. The Pd-catalyzed reactions of ethyl 4-bromo-3-oxopentanoate 2c with bicyclic adducts 1a and 1b were found to afford the products 3i and 3j in satisfactory yields (as a mixture of diastereomers) whereas the use of 4-chloro-3-oxopentanoate 2d instead of 2c resulted in better reactions affording 3i and 3j in good to excellent yields. A phenyl moiety was introduced to the fifth position of 3(2H)-furanone moiety of 3k by starting from 4-chloro-1-phenylbutane-1,3-dione 2e and bicyclic adduct 1a.
Having established a methodology for accessing 3(2H)-furanone-appended hydrazino cyclopentene from diazabicyclic olefins and 4-halo-1,3-dicarbonyl compounds, we were interested in expanding the scope of olefins used. In this line we checked the reactivity of spirotricyclic olefin 4a (derived from spiro[2.4]hepta-4,6-diene and diethylazodicarboxylate) with ethyl-4-chloro acetoacetate 2a under the optimized conditions developed for diazabicyclic olefin. As expected the 3(2H)-furanone-substituted hydrazino-spiro[2.4]hept-5-ene 5a was isolated from the reaction in 12% yield (Figure 6). A significant improvement in the yield of 5a to 81% was observed when the solvent was changed from DCE to THF.
The generality of the Pd-catalyzed ring opening of spirotricyclic olefins with 4-halo-1,3-dicarbonyl compounds were then investigated (Figure 7). The reactions of the olefins 4a–4c with 4-chloro-ethyl/methyl acetoacetates 2a-2b afforded the corresponding 3(2H)-furanone-substituted hydrazino-spiro[2.4]hept-5-enes 5a to 5d in good to excellent yields. The reactions of 4-chloro-3-oxopentanoate 2d with spirotricyclic olefins 4a & 4b also afforded the expected products 5e and 5f (as a mixture of diastereomers) in 52% and 45% yields, respectively.
We propose a mechanism for the Pd-catalyzed synthesis of 3(2H)-furanone-appended hydrazino cyclopentene from diazabicyclic olefin and 4-halo acetoacetate based on literature precedents (Figure 8) [43,44,45,46].
The reaction proceeds through three stages; the first one being the attack of Pd(0) species to the double bond (through exo-face) of the diazabicyclic olefin 1a to form the π-allylpalladium intermediate B (via A) by the cleavage of one C-N bond (endo phase). The second stage involves the attack of the anionic species C or D (generated from 2a) to one end of the π-allylpalladium intermediate (through the opposite side of that of Pd) B generating the species E. Then, the decomplexation of Pd-species from the cyclopentene ring occurs, followed by the oxidative addition of Pd(0)Ln to the C–Cl bond to form F. The intermediate F is easily converted into oxy-π-allylpalladium intermediate G and the ester enolate formed by the abstraction of the acidic proton attacks the carbon end of the oxy-π-allyl Pd-intermediate resulting in the 3(2H)-furanone ring. The classical double inversion mechanism is the reason for the cis-stereochemistry in the product.
Our next attempt was to utilize the synthesized 3(2H)-furanone-appended hydrazino cyclopentenes for the generation of biologically relevant furanone-analogues [47,48]. This transformation was effected by treating the 3(2H)-furanone-appended hydrazino cyclopentene 3 with an amine 6 in MeOH at 40 °C. These reactions were found to be completed in 12 to 24 h, from which the respective furanone-analogues 7a–d were isolated in moderate to excellent yields (Figure 9).
During the synthesis of amine-functionalized 3(2H)-furanone derivatives, we chose different ortho-bromo-benzylamines to access scaffolds that can be subjected to further transformations towards complex fused moieties. We hypothesized that, by subjecting compound 7c to intramolecular Heck coupling conditions, a tri-ring-fused azocine moiety, namely 3(2H)-furanone-fused cyclopetano-benzoazocine could be synthesized. The first trial run of the intramolecular Heck coupling of 7c was carried out with Pd(OAc)2 as the catalyst, P(o-tol)3 as the ligand, and Et3N as the base in CH3CN at 100 °C (Figure 10). After 12 h, to our dismay, we isolated the dehalogenated 3(2H)-furanone 7b. We then changed different conditions to see if the expected 3(2H)-furanone-fused cyclopetano-benzoazocine could be synthesized [49]. All the attempts were in vain, furnishing the dehalogenated product. The reason for failure might be due to the fact that oxidatively added palladium species might not be in a bonding distance with that of the alkene (of cyclopentene) for insertion reaction.

3. Materials and Methods

All chemicals were of the best grade commercially available and were used without further purification. All solvents were purified according to the standard procedures; dry solvents were obtained according to the literature methods and stored over molecular sieves. Analytical thin-layer chromatography was performed on polyester sheets precoated with silica gel containing fluorescent indicator (POLYGRAMSIL G/UV254). Gravity column chromatography was performed using silica, and mixtures of ethyl acetate hexanes were used for elution. Melting points were measured with a Fisher John melting point apparatus and are uncorrected. NMR spectra were recorded with Bruker Avance-500 (500 MHz for 1H NMR, 125 MHz for 13C NMR) spectrophotometer instruments. All spectra were measured at 300 K, unless otherwise specified. The chemical shifts δ are given in ppm and referenced to the external standard TMS or internal solvent standard. 1H NMR coupling constants (J) are reported in Hertz (Hz) and multiplicities are indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and qdd (doublet of doublets). Mass spectra were performed with a Thermo Finnigan MAT95XL, a Thermo Fisher Scientific LTQ Orbitrap Velos, and an Agilent 6890 gas chromatograph with JMS-T100GC spectrometer or with a ESI/HRMS at 60,000 resolution using Thermo Scientific Exactive mass spectrometer with orbitrap analyzer.
All chemicals were purchased from TCI Chemicals (India), Sigma-Aldrich (Merck-India) or Spectrochem (India).
4-Bromoacetoacetates and 4-Chlorooacetoacetates were prepared by the reported procedures [50,51,52].
The synthesized 3(2H)-furanone-appended cyclopentenes contains hydrazide moieties, and the peaks in 1H and 13C NMR spectra were broadened (or doubled) by the presence of amide rotamers [53].
Experimental procedure for the synthesis of 3(2H)-furanone-appended hydrazino cyclopentene: A mixture of diazabicyclic olefin (1.0 equiv.), 4-haloacetoacetate (1.5 equiv.), [Pd(allylCl)]2 (5 mol%), Xphos (10 mol%) and K2CO3 (2.0 equiv.) was weighed into a dry Schlenk tube and degassed for 10 min. Dry DCE (0.2 mM) was added and the reaction mixture was purged with argon and allowed to stir at 60 °C for 12 h. The solvent was evaporated in vacuo and the residue on silica gel (100–200 mesh) column chromatography using mixtures of hexanes/ethyl acetate as eluents, affording the corresponding 3(2H)-furanone-appended hydrazino cyclopentene.
Synthesis and characterization of 3(2H)-furanone-appended hydrazino cyclopentenes 3a to 3k:
Diethyl-1-((1S,4R)-4-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3a): The reaction was performed according to the general procedure with diazabicyclic olefin (derived from cyclopentadiene and diethylazadicarboxylate) 1a (100 mg, 0.42 mmol), ethyl-4-chloroacetoacetate 2a (103 mg, 0.62 mmol), [Pd(allyl)Cl]2 (8 mg, 0.02 mmol), Xphos (20 mg, 0.04 mmol) and K2CO3 (115 mg, 0.83 mmol) in dry DCE was stirred at 60 °C for 12 h. Upon completion of the reaction as indicated by TLC, the solvent was removed and the crude product was purified over silica gel (100–200 mesh) column chromatography (70% ethyl acetate in hexanes) to afford the product 3a as pale-yellow viscous liquid (130 mg, 85%). Analytical data of 3a: FTIR (νmax in cm−1): 3307, 2983, 2936, 1712, 1468, 1411, 1375, 1231, 1118, 1104, 1040, 953, 762, 663, 565. 1H NMR (500 MHz, CDCl3, TMS): δ 5.65–5.57 (m, 2H), 5.32 (brs, 1H), 4.46 (s, 2H), 4.42–4.38 (m 2H), 4.11 (brs, 5H), 3.42–3.40 (m, 1H), 2.51 (brs, 1H), 1.84 (brs, 1H), 1.37 (t, J = 7.0 Hz, 3H), 1.21–1.16 (m, 6H) ppm. 13C NMR (125 MHz, CDCl3): δ 195.8, 181.2, 156.8, 156.1, 136.6, 129.0, 128.4, 95.2, 74.7, 66.2, 62.2, 61.5, 36.4, 32.8, 14.7, 14.5 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C17H24N2NaO7: 391.1476; found: 391.1486
The remaining reactions were performed following this general procedure.
Diethyl-1-((1S,4R)-4-(2-methoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3b): Pale yellow viscous liquid (131 mg, 88%); 1H NMR (500 MHz, CDCl3, TMS): δ 5.64- 5.58 (m, 2H), 5.31 (brs, 1H), 4.48 (s, 2H), 4.11 (brs, 5H), 4.00 (s, 3H), 3.42–3.38 (m, 1H), 2.51 (brs, 1H), 1.82–1.80 (m, 1H), 1.20–1.16 (m, 6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.8, 181.4, 156.8, 156.0, 136.5, 128.9, 128.5, 95.3, 74.8, 66.6, 64.1, 62.1, 61.5, 56.4, 36.2, 32.7, 14.5 ppm; HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C16H22N2NaO7: 377.1319; found: 377.1364
Diisopropyl-1-((1S,4R)-4-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3c): Yellow viscous liquid (122 mg, 82%); FTIR (νmax in cm−1): 3306, 2988, 2929, 1713, 1388, 1363, 1312, 1254, 1162, 1045, 1023, 964, 866, 778, 754. 1H NMR (500 MHz, CDCl3, TMS): δ 5.66–5.58 (m, 2H), 5.33 (brs, 1H), 4.93–4.85 (m, 2H), 4.47–4.37 (m, 5H), 3.42–3.40 (m, 1H), 2.49–2.47 (m, 1H), 1.93 (brs, 1H), 1.36 (t, J = 7.0 Hz, 3H), 1.19–1.17 (m, 12H) ppm; 13C NMR (125 MHz, CDCl3): δ 195.7, 181.2, 156.3, 155.6, 136.9, 136.3, 129.2, 128.6, 95.2, 74.6, 69.5, 69.0, 66.3, 66.1, 63.8, 36.2, 29.2, 22.1, 22.0, 14.8 ppm; HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C19H28N2NaO7 419.1789; found: 419.1782.
Diisopropyl-1-((1S,4R)-4-(2-methoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3d): Yellow viscous liquid (130 mg, 87%); 1H NMR (500 MHz, CDCl3, TMS): δ 5.65- 5.58 (m, 2H), 5.32 (brs, 1H), 4.86–4.85 (m, 2H), 4.48 (s, 2H), 3.99 (s, 3H), 3.41 (brs, 1H), 2.46 (brs, 1H), 1.80 (brs, 1H), 1.18–1.17 (m, 12H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.6, 181.4, 156.3, 155.6, 155.5, 136.1, 129.2, 128.7, 95.9, 95.2, 74.7, 69.5, 69.1, 63.7, 56.5, 56.3, 36.1, 35.9, 32.7, 32.1, 22.1, 21.9 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C18H26N2NaO7: 405.1632; found: 405.1640.
Di-tert-butyl 1-((1S,4R)-4-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3e): Yellow viscous liquid (82 mg, 57%); FTIR (νmax in cm−1): 3308, 2971, 2922, 1721, 1396, 1372, 1323, 1249, 1164, 1054, 1018, 862, 763. 1H NMR (500 MHz, CDCl3, TMS): δ 5.66–5.61 (m, 2H), 5.28–5.14 (m, 1H), 4.52–4.37 (m, 5H), 3.40 (m, 1H), 2.44 (s, 1H), 1.78 (brs, 3H), 1.38–1.37 (m, 18H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.7, 181.3, 155.1, 154.8, 135.4, 129.7, 95.4, 80.6, 74.7, 66.0, 36.1, 31.9, 28.2, 28.0, 14.6 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C21H32N2NaO7: 447.2102; found: 447.2089.
Di-tert-butyl 1-((1S,4R)-4-(2-methoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3f): Yellow viscous liquid (89 mg, 64%); 1H NMR (500 MHz, CDCl3, TMS): δ 5.64 (brs, 2H), 5.28 (brs, 1H), 4.46 (s, 2H), 3.98 (s, 3H), 3.40 (s, 1H), 2.44 (brs, 1H), 1.83 (brs, 1H), 1.39–1.38 (m, 18H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.7, 181.3, 155.5, 155.0, 135.7, 129.7, 95.7, 81.0, 80.6, 74.7, 56.4, 56.2, 36.1, 33.1, 32.0, 29.7, 28.3 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C20H30N2NaO7: 433.1945; found: 433.1961.
Dibenzyl 1-((1S,4R)-4-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3g): Brown viscous liquid (90 mg, 64%); FTIR (νmax in cm−1): 3278, 3069, 3040, 2965, 1712, 1567, 1498, 1417, 1306, 1254, 1219, 1244, 1080, 1045, 750, 704, 599. 1H NMR (500 MHz, CDCl3, TMS): δ 7.24–7.19 (m, 10H), 5.62–5.32 (m, 3H), 5.08–4.99 (m, 4H), 4.48–4.36 (m, 4H), 3.39 (s, 1H), 2.51 (brs, 1H), 1.91 (brs, 1H), 1.35–1.32 (m, 3H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.9, 181.3, 156.8, 156.5, 155.8, 137.1, 136.3, 128.7, 128.4, 128.3, 128.1, 128.0, 127.9, 127.8, 127.6, 127.4, 95.0, 74.7, 67.5, 67.1, 66.8, 66.4, 64.3, 36.6, 32.3, 14.7 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C27H28N2NaO7: 515.1782; found: 515.1789.
Dibenzyl 1-((1S,4R)-4-(2-methoxy-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3h): brown viscous liquid (98 mg, 75%); 1H NMR (500 MHz, CDCl3, TMS): δ 7.24–7.21 (m, 10H), 5.62–5.38 (m, 3H), 5.08–4.99 (m, 4H), 4.50–4.39 (m, 2H), 3.96 (brs, 3H), 3.39 (s, 1H), 2.50 (brs, 1H), 1.84 (brs, 1H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 195.8, 181.4, 156.7, 155.8, 136.9, 136.3, 128.8, 128.4, 128.4, 128.0, 127.9, 95.1, 74.8, 67.6, 67.1, 64.3, 56.3, 36.4, 32.3 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C26H26N2NaO7: 501.1632; found: 501.1625
Diethyl 1-((1S,4R)-4-(2-ethoxy-5-methyl-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3i): Yellow viscous liquid (130 mg, 82%); 1H NMR (500 MHz, CDCl3, TMS): δ 5.64–5.56 (m, 2H), 5.32 (brs, 1H), 4.57–4.54 (m, 1H), 4.38–4.36 (m, 2H), 4.14–4.11 (m, 4H), 3.41–3.39 (m, 1H), 2.50 (brs, 1H), 1.90 (m, 1H), 1.41–1.40 (m, 3H), 1.36 (t, J = 7.0 Hz, 3H), 1.18–1.15 (m, 6H) ppm;13C{1H} NMR (125 MHz, CDCl3): δ 198.6, 180.0, 156.9, 156.1, 137.0, 128.8, 93.7, 82.9, 75.5, 66.1, 62.1, 36.5, 30.9, 29.7, 16.5, 14.7, 14.5 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C18H26N2NaO7: 405.1632; found: 405.1629.
Diisopropyl 1-((1S,4R)-4-(2-ethoxy-5-methyl-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3j): yellow viscous liquid (115 mg, 72%); FTIR (νmax in cm−1): 3301, 2975, 2936, 1712, 1696, 1527, 1486, 1405, 1299, 1263, 1179, 1115, 1056, 941, 761, 611. 1H NMR (500 MHz, CDCl3, TMS): δ 5.65–5.56 (m, 2H), 5.34 (brs, 1H), 4.91–4.85 (m, 2H), 4.52–4.51 (m, 1H), 4.38–4.37 (m, 2H), 3.40 (brs, 1H), 2.46 (brs, 1H), 1.92 (brs, 1H), 1.41–1.34 (m, 6H), 1.18 (brs, 12H) ppm;13C{1H} NMR (125 MHz, CDCl3): δ 198.4, 179.9, 156.4, 155.7, 136.6, 129.0, 128.4, 93.5, 82.9, 69.5, 66.0, 36.5, 32.3, 22.1, 22.0, 16.6, 14.8 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C20H30N2NaO7: 433.1945; found: 433.1956.
Diethyl 1-((1S,4R)-4-(4-oxo-2-phenyl-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (3k): (This reaction was performed at rt) pale yellow viscous liquid (90 mg, 35%); FTIR (νmax in cm−1): 3331, 2976, 2936, 1701, 1596, 1410, 1381, 1266, 1231, 1167, 1144, 1069. 947. 821, 761, 704, 651, 501, 431. 1H NMR (500 MHz, CDCl3, TMS): δ 7.77–7.73 (m, 2H), 7.45 (brs, 1H), 7.43–7.20 (m, 2H), 5.99 (s, 1H), 5.79–5.73 (m, 2H), 4.22–4.17 (m, 2H), 4.11–4.10 (m, 5H), 3.15 (brs, 1H), 2.52 (brs, 1H), 1.94 (brs, 1H), 1.25–1.13 (m, 6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 203.3, 185.9, 155.8, 154.4, 152.2, 132.8, 128., 127.1, 101.5, 87.3, 62.9,62.5, 62.0, 46.5, 30.9, 2.7, 14.5,14.1,14.1 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C21H24N2NaO6: 423.1527; found: 423.1532.
Experimental procedure for the synthesis of 3(2H)-furanone-appended hydrazino-spiro[2.4]hept-5-enes from spirotricyclic olefin and 4-halo-1,3-dicarbonyl compounds: A mixture of spirotricyclic olefin (1.0 equiv.), 4-haloacetoacetate (1.5 equiv.), [Pd(allylCl)]2 (5 mol%), Xphos (10 mol%) and K2CO3 (2.0 equiv.) was weighed in a Schlenk tube and degassed for 10 min. Dry THF (0.2 mM) was added and the reaction mixture was purged with argon and allowed to stir at 60 °C for 12h. The solvent was evaporated in vacuo and the residue on silica gel (100–200 mesh) column chromatography yielded 3(2H)-furanone-appended hydrazino-spiro[2.4]hept-5-enes.
Synthesis and characterization of 3(2H)-furanone-appended hydrazino-spiro[2.4]hept-5-enes:
Diethyl 1-((4R,7S)-7-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5a): Following the general experimental procedure, spirotricyclic olefin 4a (derived from spiro[2.4]hepta-4,6-diene and diethylazodicarboxylate) (100 mg, 0.3755 mmol), ethyl-4-chloroacetoacetate 2a (92.7 mg, 0.56 mmol), [Pd(allyl)Cl]2 (7 mg, 0.02 mmol), Xphos (18 mg, 0.04 mmol) and K2CO3 (104 mg, 0.75 mmol) in dry THF (1.9 mL) was stirred at 60 °C for 12h. The crude product was purified over silica gel (100–200 mesh) column chromatography (50% ethyl acetate in hexanes) to afford the desired product 5a as pale brown viscous liquid (120 mg, 81%). Analytical data of 5a: FTIR (νmax in cm−1): 3289, 2959, 222, 2861, 1697, 1412, 1309, 1263, 1118, 1024, 966, 798. 1H NMR (500 MHz, Acetone-d6, TMS): δ 9.28 (brs, 0.48H) 5.73–5.57 (m, 2H), 5.00–4.91 (m, 1H), 4.51–4.49 (m, 2H), 4.37 (q, J = 7 Hz, 1H), 4.01–3881 (m, 4H), 3.19 (brs, 1H), 1.28–1.24 (m, 3H), 1.10–1.03 (m, 6H), 0.82–0.75 (m, 1H), 0.52–0.47 (m, 1H), 0.42–0.37 (m, 1H), 0.28–0.23 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 195.6, 182.0, 156.9, 156.4, 137.6, 127.9, 92.4, 74.7, 69.7, 69.5, 66.4, 61.3, 60.4, 45.1, 27.1, 17.0, 14.1, 14.0, 13.9, 9.2 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C19H26N2NaO7: 417.1632; found: 417.1639.
The remaining reactions were performed following this general procedure.
Diethyl 1-((4R,7S)-7-(2-methoxy-4-oxo-4,5-dihydrofuran-3-yl) spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5b): Pale brown viscous liquid (107 mg, 76%); 1H NMR (500 MHz, Acetone-d6, TMS): δ 9.21 (brs, 0.47H), 5.75–5.57 (m, 2H), 5.00–4.90 (m, 1H), 4.52–4.50(m, 2H), 3.99–3.90 (m, 7H), 3.19–3.18 (m, 1H), 1.10–1.03 (m, 6H), 0.81–0.77 (m, 1H), 0.54–0.47 (m, 1H), 0.41–0.36 (m, 1H), 0.30–0.22 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 195.5, 182.2, 156.9, 156.5, 137.5, 127.9, 92.3, 74.7, 69.7, 61.2, 60.5, 56.3, 45.0, 27.1, 17.0, 14.1, 14.0, 9.2 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C18H24N2NaO7: 403.1476; found: 403.1472.
Diisopropyl 1-((4R,7S)-7-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl) spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5c): pale yellow viscous liquid (111 mg, 75%); FTIR (νmax in cm−1): 3336, 2976, 2930, 1718, 1457, 1393, 1379, 1318, 1248, 1156, 1050, 1026, 849, 773. 1H NMR (500 MHz, Acetone-d6, TMS): δ 9.04 (brs, 0.50H), 5.75–5.68 (m, 1H), 5.58–5.57 (m, 1H), 5.00–4.88 (m, 1H), 4.78–4.64 (m, 3H), 4.50–4.80 (m, 2H), 4.37 (q, J = 7.0 Hz, 2H), 3.19 (brs, 1H), 1.27–1.25 (m, 3H), 1.12–1.03 (m, 12H), 0.81–0.73 (m, 1H), 0.51–0.46 (m, 1H), 0.42–0.38 (m, 1H), 0.27–0.22 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 186.1, 172.4, 157.0, 128.4, 128.3, 128.1, 126.7, 100.7, 70.8, 65.9, 60.8, 31.7, 30.8, 27.2, 24.8, 22.4, 21.3, 13.9, 13.4 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C21H30N2NaO7: 445.1945; found: 445.1951.
Di-tert-butyl 1-((4R,7S)-7-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl) spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5d): pale yellow viscous liquid (111 mg, 65%); FTIR (νmax in cm−1): 3296, 2983, 2941, 1712, 1573, 1446, 1382, 1301, 1242, 1179, 1115, 1045, 70, 866, 790, 766. 1H NMR (500 MHz, Acetone-d6, TMS): δ 8.80 (brs, 0.33H), 5.73–5.53 (m, 2H), 4.98–4.83 (m, 1H), 4.54–4.45 (m, 2H), 4.37 (m, 2H), 3.19 (brs, 1H), 1.34–1.24(m, 18H), 1.05 (brs, 3H), 0.79–0.76 (m, 1H), 0.50–0.40 (m, 2H), 0.30–0.18 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 178.8, 174.5, 174.1, 156.1, 155.8, 136.0, 131.0, 100.1, 79.7, 66.2, 61.2, 57.0, 45.7, 38.2, 27.6, 27.4, 26.6, 17.7, 13.6, 9.2 ppm. HRMS (ESI-Orbitrap) m/z: (M + H)+ calcd for C23H34N2NaO7: 473.2258; found: 473.2269.
Diethyl 1-((4R,7S)-7-(2-ethoxy-5-methyl-4-oxo-4,5-dihydrofuran-3-yl)spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5e): pale yellow viscous liquid (80 mg, 52%); 1H NMR (500 MHz, Acetone-d6, TMS): δ 9.22–9.18 (m, 0.66H), 5.75–5.53 (m, 2H), 4.99–4.87 (m, 1H), 4.60 (m, 1H), 3.99–3.91 (m, 7H), 3.17 (brs, 1H), 1.31–1.28 (m, 3H), 1.17–1.16 (m, 3H), 1.10–1.03 (m, 6H), 0.79–0.74 (m, 1H), 0.52–0.49 (m, 1H), 0.42–0.36 (m, 1H), 0.29–0.15 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 197.9, 181.0, 156.8, 156.4, 137.7, 127.9, 127.8, 91.0, 83.0, 82.9, 69.7, 61.2, 60.4, 56.4, 45.0, 27.1, 17.2, 16.0, 15.9, 14.1, 14.0, 13.9, 9.2 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C20H28N2NaO7: 431.1789; found: 431.1784.
Diisopropyl 1-((4R,7S)-7-(2-ethoxy-5-methyl-4-oxo-4,5-dihydrofuran-3-yl)spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (5f): pale yellow viscous liquid (70 mg, 45%); 1H NMR (500 MHz, Acetone-d6, TMS): δ 9.15–9.10 (m, 0.54H), 5.72–5.57 (m, 2H), 5.00–4.87 (m, 1H), 4.71–4.66 (m, 2H), 4.59–4.57 (m, 1H), 4.36 (m, 2H), 3.18 (brs, 1H), 1.30–1.23 (m, 6H), 1.12–1.01 (m, 12H), 0.79–0.70 (m, 1H), 0.50–0.46 (m, 1H), 0.44–0.34 (m, 1H), 0.30–0.14 (m, 1H) ppm; 13C{1H} NMR (125 MHz, Acetone-d6): δ 198.0, 180.6, 156.3, 156.0, 137.5, 128.0, 91.0, 82.8, 82.7, 69.6, 68.5, 67.8, 66.2, 44.8, 36.4, 27.2, 21.4, 21.3, 16.9, 16.1, 14.0, 9.1 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C22H32N2NaO7: 459.2102; found: 459.2109
Experimental procedure for the synthesis of amine-functionalized 3-(2H)-furanone-appended hydrazino cyclopentenes: A mixture of 3-(2H)-furanone-appended hydrazino cyclopentene (1.0 equiv.,) and amine (1.1 equiv) was weighed into a dry Schlenk tube. Dry methanol (0.2 mM) was added, and the reaction mixture was stirred at 40 °C. Upon completion of the reaction, the solvent was removed, and the residue was subjected to column chromatography on neutral alumina using hexanes/ethyl acetate mixture as eluent to afford the amine-functionalized 3-(2H)-furanone appended hydrazino cyclopentene.
Synthesis and characterization of amine-functionalized 3-(2H)-furanone-appended hydrazino cyclopentenes:
Dibenzyl 1-((1S,4R)-4-(2-(hexylamino)-4-oxo-4,5-dihydrofuran-3-yl) cyclopent-2-en-1-yl) hydrazine-1,2-dicarboxylate (7a): Following the general experimental procedure, 3-(2H)-furanone-appended hydrazino cyclopentene 3h (50 mg, 0.10 mmol) and n-hexyl amine 6a (11.3 mg, 0.11 mmol) was weighed into a dry Schlenk tube. Dry methanol (0.5 mL) was added, and the reaction mixture was stirred at 40 °C for 12h. Upon completion of the reaction, the solvent was removed, and the residue was subjected to column chromatography on neutral alumina using hexanes/ethyl acetate mixture as eluent (60% ethyl acetate in hexanes) to afford the desired product 7a as pale-yellow viscous liquid (54 mg, 98%). Analytical data of 7a: FTIR (νmax in cm−1): 3463, 3284, 2983, 2948, 1712, 1545, 1510, 1452, 1400, 1254, 1214, 1109, 1045, 744, 692, 587, 506. 1H NMR (500 MHz, CDCl3, TMS): δ 7.24–7.19 (m, 10H), 5.81 (brs, 1H), 5.59 (brs, 1H), 5.06–5.04 (m, 4H), 4.87 (brs, 1H), 4.36 (s, 2H), 3.65 (brs, 1H), 3.20–3.12 (m, 2H), 2.58 (brs, 1H), 1.77 (brs, 1H), 1.45–1.53 (m, 2H), 1.21–1.18 (m, 6H), 0.80 (t, J = 6.5Hz, 3H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 191.4, 177.5, 156.7, 155.4, 135.8, 130.9, 128.6, 128.4, 128.2, 128.1, 127.7, 93.4, 74.1, 67.9, 67.7, 41.5, 35.8, 31.3, 29.9, 26.9, 26.3, 22.5, 14.0 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C31H37N3NaO6: 570.2575; found: 570.2579.
The remaining reactions were performed following this general procedure:
Dibenzyl 1-((1S,4R)-4-(2-(benzylamino)-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (7b): Pale yellow viscous liquid (52 mg, 92%); FTIR (νmax in cm−1): 3463, 3259, 3069, 3040, 2948, 1706, 1556, 1499, 1463, 1417, 1208, 1057, 1005, 750, 611, 576, 495. 1H NMR (500 MHz, CD3CN, TMS): δ 7.25–7.20 (m, 15H), 5.61–5.53 (m, 2H), 5.14–4.95 (m, 5H), 4.39–4.38 (m, 2H), 4.21 (brs, 2H), 3.35 (brs, 1H), 2.46–2.43 (m, 1H), 1.84 (brs, 1H); 13C{1H} NMR (125 MHz, CD3CN): δ 192.6, 178.1, 157.5, 156.1, 137.3, 129.2, 129.0, 128.5, 128.1, 128.0, 127.8, 93.0, 74.6, 67.8, 66.9, 65.6, 45.0, 37.4, 33.1 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C32H31N3NaO6: 576.2105; found: 576.2118.
Dibenzyl-1-((1S,4R)-4-(2-((2-bromobenzyl)amino)-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate (7c): Pale yellow viscous liquid (46 mg, 72%); FTIR (νmax in cm−1): 3492, 3267, 2983, 2924, 2885, 1719, 1596, 1336, 1242, 1057, 1028, 756, 675, 582. 1H NMR (500 MHz, CDCl3, TMS): δ 7.49 (d, J = 8Hz, 1H), 7.25–7.11 (m, 13H), 5.66–5.58 (m, 2H), 5.14–4.94 (m, 5H), 4.45 (s, 2H), 4.21 (s, 2H), 3.41 (brs, 1H), 2.52–2.45 (m, 1H), 1.85 (brs, 1H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 192.1, 177.4, 156.6, 155.4, 136.8, 135.8, 135.7, 132.9, 131.1, 129.2, 128.9, 128.5, 128.4, 128.2, 128.1, 127.8, 127.7, 122.9, 94.2, 74.2, 67.9, 67.7, 45.3, 35.7 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C32H30N3NaO6Br: 654.1210; found: 654.1195.
Diethyl-1-((4R,7S)-7-(2-((2-bromobenzyl)amino)-4-oxo-4,5-dihydrofuran-3-yl)spiro[2.4]hept-5-en-4-yl)hydrazine-1,2-dicarboxylate (7d): Pale yellow viscous liquid (35 mg, 50%); 1H NMR (500 MHz, CDCl3, TMS): δ 7.50 (d, J = 7.5 Hz, 1H), 7.25 (t, J = 7.0 Hz, 2H), 7.11 (t, J = 7Hz, 1H), 5.94–5.82 (m, 2H), 4.58–4.50 (m, 2H), 4.45–4.35 (m, 3H), 4.17–4.00 (m, 4H), 3.73 (brs, 1H), 1.18–1.12 (m, 7H), 0.81–0.79 (m, 2H), 0.44–0.37 (m, 1H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 192.2, 177.8, 177.5, 157.3, 136.9, 133.5, 131.0, 129.4, 128.4, 127.8, 123.1, 74.3, 62.4, 45.4, 43.2, 29.7, 14.3, 10.5 ppm. HRMS (ESI-Orbitrap) m/z: (M + Na)+ calcd for C24H28N3NaO6Br:556.1054; found: 556.1059.
Experimental procedure for the intramolecular Heck reaction of amine-functionalized 3-(2H)-furanone-appended hydrazino cyclopentenes: A mixture of amine-functionalized 3-(2H)-furanone-appended hydrazino cyclopentenes (1.0 equiv.), Pd(OAc)2 (5 mol%), P(o-tol)3 (10 mol%) and Et3N (1.0 equiv.) was weighed in a Schlenk tube and degassed for 10 min. Dry ACN (0.025 mM) was added and the reaction mixture was purged with argon and allowed to stir at 100 °C for 12h. The solvent was evaporated in vacuo and the residue on silica gel (100–200 mesh) column chromatography yielded compound 8.
Following the general experimental procedure, Dibenzyl-1-((1S,4R)-4-(2-((2-bromobenzyl)amino)-4-oxo-4,5-dihydrofuran-3-yl)cyclopent-2-en-1-yl)hydrazine-1,2-dicarboxylate 7c (32 mg, 0.0506 mmol) Pd(OAc)2 (0.51 mg, 0.0025 mmol), P(o-tol)3 (1.6 mg, 0.0051 mmol) and Et3N (5.1 mg, 0.0506 mmol) was weighed in a Schlenk tube and degassed for 10 min. Dry ACN (2 mL) was added and the reaction mixture was purged with argon and allowed to stir at 100 °C for 12h. Upon completion of the reaction, the solvent was removed, and the residue was subjected to column chromatography on silica gel (100–200 mesh) using hexanes/ethyl acetate mixture as eluent (70% ethyl acetate in hexanes) to afford the 8c as pale-yellow viscous liquid (18 mg, 65%). Analytical data was the same as 7b.

4. Conclusions

We have developed a methodology for the ring-opening of diazabicyclic olefins via a Pd-catalyzed reaction with 4-halo-1,3-dicarbonyl compounds. This reaction has resulted in the generation of a new class of 3(2H)-furanone-appended hydrazino cyclopentenes. This ring opening reaction of diazabicyclic olefins was found to be general with different 4-halo-1,3-dicarbonyl compounds and we could also synthesize another interesting scaffold, namely, 3(2H)-furanone-substituted spiro[2.4]hept-5-ene from cyclopropane-appended spirotricyclic olefin. We have proposed a mechanism which proceeds via the formation of a π-allylpalladium intermediate, which is quenched by the active methylene moiety generated from 4-halo1,3-dicarbonyl moiety, and an intramolecular cyclization in the intermediate then generates the product. We then utilized the synthesized 3(2H)-furanone-appended hydrazino cyclopentenes for the generation of amine-functionalized 3-(2H)-furanone-appended hydrazino cyclopentenes. Finally, we tried to generate a new family of 3(2H)-furanone-fused tetrahydroazocine derivatives which did not result in the expected outcome.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/org4010006/s1, Table S1: Optimization studies for intramolecular Heck coupling; Figure S1: 1H NMR and 13C NMR Spectra of 3a; Figure S2: 1H-1H COSY Spectrum of 3a; Figure S3: HMQC Spectrum of 3a; Figure S4: HMBC Spectrum of 3a; Figure S5: 1D-NOE Spectrum of 3a; Figure S6: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3b; Figure S7: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3c; Figure S8: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3d; Figure S9: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3e; Figure S10: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3f; Figure S11: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3g; Figure S12: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3h; Figure S13: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3i; Figure S14: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 3j; Figure S15: 1H NMR (500 MHz) & 13C (125 MHz) spectra of 3k; Figure S16: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5a; Figure S17: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5b; Figure S18: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5c; Figure S19: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5d; Figure S20: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5e; Figure S21: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 5f; Figure S22: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 7a; Figure S23: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 7b; Figure S24: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 7c; Figure S25: 1H NMR (500 MHz) & 13C (125 MHz) Spectra of 7d.

Author Contributions

Conceptualization, J.J.; methodology, J.J., V.K.O. and A.V.; validation, J.J. and V.K.O.; formal analysis, J.J. and V.K.O. investigation J.J., V.K.O. and A.V. writing—original draft preparation, J.J. and V.K.O. writing—review and editing, J.J. and H.H. supervision, J.J.; project administration, J.J.; funding acquisition, J.J. All authors have read and agreed to the published version of the manuscript.

Funding

V.K.O. and A.V. thank UGC and CSIR for research fellowship. J.J. thanks CSIR (HCP-029 & OLP-162539), AICTE (GAP-161939) and Alexander von Humboldt Foundation for financial assistance.

Data Availability Statement

All data supporting the reported results can be found in the Supporting Information file.

Acknowledgments

The authors thank Saumini Mathew and Viji S. of CSIR-NIIST for recording NMR and mass spectra respectively.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Colin Slaughter, J.C. The naturally occurring furanones: Formation and function from pheromone to food. Biol. Rev. 1999, 74, 259. [Google Scholar] [CrossRef] [PubMed]
  2. Carter, N.B.; Nadanya, A.E.; Sweeney, J.B. Recent developments in the synthesis of furan-2(5H)-ones. J. Chem. Soc. Perkin Trans. 1. 2002, 2324. [Google Scholar] [CrossRef]
  3. de Nys, R.; Givskov, M.; Kumar, N.; Kjelleberg, S.; Steinberg, P.D. Marine Molecular Biotechnology; Fusetani, N., Clare, A.S., Eds.; Springer: Berlin/Heidelberg, Germany, 2006; Volume 42. [Google Scholar]
  4. Schwab, W. Natural 4-Hydroxy-2,5-dimethyl-3(2H)-furanone. Molecules 2013, 18, 6936. [Google Scholar] [CrossRef]
  5. Husain, A.; Khan, S.A.; Iram, F.; Iqbal, M.A.; Asif, M. Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore. Eur. J. Med. Chem. 2019, 171, 66. [Google Scholar] [CrossRef] [PubMed]
  6. Smith, A.B., III; Levenberg, P.A.; Jerris, P.J.; Scarborough, R.M., Jr.; Wovkulich, P.M. Synthesis and reactions of simple 3(2H)-furanones. J. Am. Chem. Soc. 1981, 103, 1501. [Google Scholar] [CrossRef]
  7. Jerris, P.J.; Smith, A.B., III. Synthesis and configurational assignment of geiparvarin: A novel antitumor agent. J. Org. Chem. 1981, 46, 577. [Google Scholar] [CrossRef]
  8. Marson, C.M.; Edaan, E.; Morrell, J.M.; Coles, S.J.; Hursthouse, M.B.; Davies, D.T. A catalytic asymmetric protocol for the enantioselective synthesis of 3(2H)-furanones. Chem. Commun. 2007, 2494. [Google Scholar] [CrossRef] [PubMed]
  9. Haug, T.T.; Kirsch, S.F. Synthesis and chemistry of 3(2H)-furanones. Targets Heterocycl. Syst. 2009, 13, 57. [Google Scholar]
  10. Omanakuttan, V.K.; John, J.; Hopf, H. Synthesis of 3(2H)-furanones-a review. Eur. J. Org. Chem. 2021, 2021, 163. [Google Scholar] [CrossRef]
  11. Dou, X.; Han, X.; Lu, Y. From the Feist–Bénary Reaction to Organocatalytic Domino Michael–Alkylation Reactions: Asymmetric Synthesis of 3(2H)-Furanones. Chem. Eur. J. 2012, 18, 85. [Google Scholar] [CrossRef]
  12. Yan, Y.-Y.; Lu, R.-J.; Wang, J.-J.; Xuan, Y.-N.; Yan, M. Synthesis of chiral tetronic acid derivatives via organocatalytic conjugate addition of ethyl 4-chloro-3-oxobutanoate to nitroalkenes. Tetrahedron 2012, 68, 6123. [Google Scholar] [CrossRef]
  13. Zhou, J.; Bai, L.; Liang, G.; Chen, Y.; Gan, Z.; Wang, W.; Zhou, H.; Yu, Y. Organocatalytic asymmetric domino Michael/O-alkylation reaction for the construction of succinimide substituted 3(2H)-furanones catalyzed by quinine. RSC Adv. 2017, 7, 39885. [Google Scholar] [CrossRef]
  14. John, J.; Hopf, H. Substituted 3(2H)-Furanones by a Tandem Michael Addition/Palladium-Catalyzed Ring-Closing Protocol. Eur. J. Org. Chem. 2013, 2013, 841. [Google Scholar] [CrossRef]
  15. John, J.; Târcoveanu, E.; Jones, P.G.; Hopf, H. A tandem Mannich addition–palladium catalyzed ring-closing route toward 4-substituted-3-(2H)-furanones. Beilstein J. Org. Chem. 2014, 10, 1462. [Google Scholar] [CrossRef] [PubMed]
  16. John, J.; Omanakuttan, V.K.; Aneeja, T.; Suresh, C.H.; Jones, P.G.; Hopf, H. Tandem α-Arylation/Cyclization of 4-Haloacetoacetates with Arynes: A Metal-Free Approach toward 4-Aryl-3-(2H)-furanones. J. Org. Chem. 2019, 84, 5957. [Google Scholar] [CrossRef]
  17. Omanakuttan, V.K.; Santhini, P.V.; Shaludheen, S.; Varughese, S.; Hopf, H.; John, J. Tandem Reaction of 4-Halo-1,3-Dicarbonyl Compounds with Alkynes towards 4-Vinyl-3(2H)-Furanones and 3(2H)-Furanone fused 2-Pyridones. Asian J. Org. Chem. 2022, 11, e202200410. [Google Scholar] [CrossRef]
  18. Bournaud, C.; Chung, F.; Luna, A.; Pasco, M.; Errasti, G.; Lecourt, T.; Micouin, L. Stereoselective Transformations of meso Bicyclic Hydrazines: Versatile Access to Functionalized Aminocyclopentanes. Synthesis 2009, 2009, 869. [Google Scholar] [CrossRef]
  19. Sajisha, S.; Anas, S.; John, J.; Radhakrishnan, K.V. Desymmetrization of meso-Bicyclic Hydrazines: An Efficient Strategy towards the Synthesis of Functionalized Cyclopentenes. Synlett 2009, 2009, 2885. [Google Scholar] [CrossRef]
  20. Pineschi, M. The Binomial Copper-Catalysis and Asymmetric Ring Opening of Strained Heterocycles: Past and Future Challenges. Eur. J. Org. Chem. 2020, 2020, 2643. [Google Scholar] [CrossRef]
  21. Preethalayam, P.; Jijy, E.; Prakash, P.; Sarngadharan, S.C.; Vijayan, A.; Radhakrishnan, K.V.; John, J. Diazanorbornene: A Valuable Synthon towards Carbocycles and Heterocycles. Eur. J. Org. Chem. 2020, 2020, 6588. [Google Scholar] [CrossRef]
  22. Allred, E.L.; Anderson, C.L.; Smith, R.L. Hydroboration of 2,3-dicarbomethoxy-2,3-diazabicyclo [2.2.1]hept-5-ene. The elimination mechanism of the organoborane intermediate. Tetrahedron Lett. 1966, 9, 951. [Google Scholar] [CrossRef]
  23. Wilson, R.M.; Schnapp, K.A.; Merwin, R.K.; Ranganathan, R.; Moats, D.L.; Conrad, T.T. Synthesis of allylic alcohol single-chain PGH analogs. A synthetic application of the argon laser. J. Org. Chem. 1986, 51, 4028. [Google Scholar] [CrossRef]
  24. Bournaud, C.; Lecourt, T.; Micouin, L.; Méliet, C.; Agbossou-Niedercorn, F. Desymmetrization of meso-Bicyclic Hydrazines by Rhodium-Catalyzed Enantioselective Hydroformylation. Eur. J. Org. Chem. 2008, 2008, 2298. [Google Scholar] [CrossRef]
  25. Mellor, J.M.; Smith, N.M. Reductive cleavage of the nitrogen–nitrogen bond in hydrazine derivatives. J. Chem. Soc., Perkin Trans. 1 1984, 2927–2931. [Google Scholar] [CrossRef]
  26. Grabowski, S.; Armbruster, J.; Prinzbach, H. Biocatalysis in the chiral recognition of meso-diamides—An efficient route from cyclic olefinic hydrocarbons to optically pure diamino-polyols. Tetrahedron Lett. 1997, 38, 5485. [Google Scholar] [CrossRef]
  27. Storsberg, J.; Nandakumar, M.V.; Sankaranarayanan, S.; Kaufmann, D.E. Stereoselective Palladium-Catalyzed C-C Coupling Reactions with a Diazabicyclo [2.2.1]heptane. Adv. Synth. Catal. 2001, 343, 177. [Google Scholar] [CrossRef]
  28. Yao, M.-L.; Adiwidjaja, G.; Kaufmann, D.E. Two-Step, Stereoselective Hydrazidoarylation of 1,3-Cyclopentadiene. Angew. Chem. Int. Ed. 2002, 41, 3375. [Google Scholar] [CrossRef]
  29. Radhakrishnan, K.V.; Sajisha, V.S.; Anas, S.; Krishnan, K.S. Palladium-Catalyzed Reaction of Bicyclic Hydrazines with Allyl- and Arylstannanes in Ionic Liquid [bmim]PF6: A Facile Method for the Synthesis of Substituted Hydrazinocyclopentene Derivatives. Synlett 2005, 2005, 2273. [Google Scholar] [CrossRef]
  30. Sajisha, V.S.; Mohanlal, S.; Anas, S.; Radhakrishnan, K.V. A facile synthesis of 3-allyl-4-hydrazinocyclopentenes by the palladium/Lewis acid mediated ring opening of bicyclic hydrazines with allyltributyltin and allyltrimethylsilane. Tetrahedron 2006, 62, 3997. [Google Scholar] [CrossRef]
  31. Sajisha, V.S.; Radhakrishnan, K.V. Palladium/Lewis Acid-Catalyzed Reactions of Bicyclic Hydrazines with Organostannanes: A General Methodology for the Stereoselective Synthesis of 3,4-Disubstituted Cyclopentenes. Adv. Synth. Catal. 2006, 348, 924. [Google Scholar] [CrossRef]
  32. John, J.; Sajisha, V.S.; Mohanlal, S.; Radhakrishnan, K.V. Iodine assisted modified Suzuki type reaction of bicyclic hydrazines: Stereoselective synthesis of functionalized cyclopentene. Chem. Commun. 2006, 3510–3512. [Google Scholar] [CrossRef]
  33. Bournaud, C.; Falciola, C.; Lecourt, T.; Rosset, S.; Alexakis, A.; Micouin, L. On the Use of Phosphoramidite Ligands in Copper-Catalyzed Asymmetric Transformations with Trialkylaluminum Reagents. Org. Lett. 2006, 8, 3581. [Google Scholar] [CrossRef] [PubMed]
  34. Anas, S.; John, J.; Sajisha, V.S.; Rajan, R.; Suresh, E.; Radhakrishnan, K.V. Iodine assisted palladium catalyzed ring opening of bicyclic hydrazines with organoboronic acids: Stereoselective synthesis of functionalized cyclopentenes and alkylidene cyclopentenes. Org. Biomol. Chem. 2007, 5, 4010. [Google Scholar] [CrossRef]
  35. John, J.; Anas, S.; Sajisha, V.S.; Viji, S.; Radhakrishnan, K.V. Palladium-catalyzed ring opening of azabicyclic olefins with organoindium reagents: A simple, clean, and efficient synthesis of functionalized cyclopentenes. Tetrahedron Lett. 2007, 48, 7225. [Google Scholar] [CrossRef]
  36. John, J.; Adarsh, B.; Radhakrishnan, K.V. Palladium catalyzed ring opening of azabicyclic olefins with organoindium and gallium reagents: A facile access towards benzylated cyclopentanoids. Tetrahedron 2010, 66, 1383. [Google Scholar] [CrossRef]
  37. Joseph, N.; Rajan, R.; John, J.; Devika, N.V.; Chand, S.S.; Suresh, E.; Pihko, P.M.; Radhakrishnan, K.V. An exclusive approach to 3,4-disubstituted cyclopentenes and alkylidene cyclopentenes via the palladium catalyzed ring opening of azabicyclic olefins with aryl halides. RSC Adv. 2013, 3, 7751. [Google Scholar] [CrossRef]
  38. John, J.; Indu, U.; Suresh, E.; Radhakrishnan, K.V. Palladium Catalyzed Tandem Ring Opening−Ring Closing Reaction of Diazabicyclic Alkenes: A Facile One Pot Strategy for Cyclopentannulation of Heterocycles. J. Am. Chem. Soc. 2009, 131, 5042. [Google Scholar] [CrossRef] [PubMed]
  39. John, J.; Rajan, R.; Chand, S.S.; Prakash, P.; Joseph, N.; Suresh, E.; Radhakrishnan, K.V. Palladium catalyzed reaction of ortho-functionalized aryl iodides with bicyclic hydrazines: Facile route toward heteroannulated cyclopentenes and azabicycles. Tetrahedron 2013, 69, 152. [Google Scholar] [CrossRef]
  40. Jijy, E.; Prakash, P.; Shimi, M.; Pihko, P.M.; Joseph, N.; Radhakrishnan, K.V. Rhodium catalyzed oxidative coupling of salicylaldehydes with diazabicyclic olefins: A one pot strategy involving aldehyde C–H cleavage and π-allyl chemistry towards the synthesis of fused ring chromanones. Chem. Commun. 2013, 49, 7349. [Google Scholar] [CrossRef]
  41. Santhini, P.V.; Nimisha, G.; John, J.; Suresh, E.; Varma, R.L.; Radhakrishnan, K.V. Pd-Catalyzed oxidative annulation of enamides with diazabicyclic olefins: Rapid access to cyclopentene fused 2-pyrrolines. Chem. Commun. 2017, 53, 1848. [Google Scholar] [CrossRef]
  42. Santhini, P.V.; Smrithy, A.S.; Jesin, C.P.I.; Varughese, S.; John, J.; Radhakrishnan, K.V. Accessing highly functionalized cyclopentanoids via a cascade palladation approach: Unprecedented benzylic C–H activation towards cyclopentenoindanes. Chem. Commun. 2018, 54, 2982. [Google Scholar] [CrossRef] [PubMed]
  43. Luna, A.P.; Cesario, M.; Bonin, M.; Micouin, L. Stereoselective Ring Opening of meso Bicyclic Hydrazines:  A Straightforward Approach to Hydrazino Cyclopentenic Cores. Org. Lett. 2003, 5, 4771. [Google Scholar] [CrossRef] [PubMed]
  44. Rajan, R.; John, J.; Thulasi, S.; Joseph, N.; Radhakrishnan, K.V.; Sawant, R.C. Trapping the π-Allylpalladium Intermediate from Fulvene-Derived Azabicyclic Olefin with Soft Nucleophiles. Synthesis 2010, 2010, 3649. [Google Scholar] [CrossRef]
  45. Jijy, E.; Prakash, P.; Baiju, V.; Shimi, M.; Yamamoto, Y.; Suresh, E.; Radhakrishnan, K.V. Palladium-Catalyzed Ring Opening of Cyclopropane-Appended Spirotricyclic Olefins with Soft Nucleophiles and Organoboronic Acids: Facile Synthesis of Functionalized Spiro [2.4]heptenes. Synthesis 2014, 46, 2629. [Google Scholar] [CrossRef]
  46. Negishi, E. Hand Book of Organopalladium Chemistry for Organic Synthesis; Wiley-Interscience: New York, NY, USA, 2002; Volume 2. [Google Scholar]
  47. Pashkovskii, F.S.; Shchukina, E.M.; Gribovskii, M.G.; Lakhvich, F.A. Heterocyclic Analogs of Prostaglandins: III. Synthesis of 10-Oxa-13-Aza, 11-Oxa-13-Aza, and 9-Oxa-7-Aza Prostanoids from 3-Acyl-and 3-(3-Arylprop-2-enoyl)Furan-2,4-Diones. Russ. J. Org. Chem. 2006, 42, 527. [Google Scholar] [CrossRef]
  48. Sutharchanadevi, M.; Murugan, R. 9.18—Eight-membered Rings with One Nitrogen Atom; Katritzky, A.R., Rees, C.W., Scriven, E.F.V., Eds.; Comprehensive Heterocyclic Chemistry II: Pergamon, Turkey, 1996; pp. 403–428. [Google Scholar]
  49. Listratova, A.V.; Voskressensky, L.G. Recent Advances in the Synthesis of Hydrogenated Azocine-Containing Molecules. Synthesis 2017, 49, 3801. [Google Scholar]
  50. Mack, R.A.; Zazulak, W.I.; Radov, L.A.; Baer, J.E.; Stewart, J.D.; Elzer, P.H. Drug-induced modifications of the immune response. 12. 4,5-Dihydro-4-oxo-2-(substituted amino)-3-furancarboxylic acids and derivatives as novel antiallergic agents. J. Med. Chem. 1988, 31, 1918. [Google Scholar] [CrossRef]
  51. Choi, H.Y.; Chi, D.Y. Nonselective bromination-selective debromination strategy: Selective bromination of unsymmetrical ketones on singly activated carbon against doubly activated carbon. Org. Lett. 2003, 5, 411. [Google Scholar] [CrossRef]
  52. Takaaki, K.; Katsumasa, H. Preparation of γ-Halogeno-β-keto esters, Japan. Patent Application No. JP1999-56383; Patent No. JP2000256262, 19 September 2000. [Google Scholar]
  53. Hu, D.; Grice, P.; Ley, S.V. Rotamers or diastereomers? An overlooked NMR solution. J. Org. Chem. 2012, 77, 5198. [Google Scholar]
Organics 04 00006 g001 550
Figure 1. Synthesis of functionalized 3(2H)-furanones from 4-haloacetoacetate [11,12,13,14,15,16].
Figure 1. Synthesis of functionalized 3(2H)-furanones from 4-haloacetoacetate [11,12,13,14,15,16].
Organics 04 00006 g001
Organics 04 00006 g002 550
Figure 2. Pd-catalyzed ring-opening of heterobicyclic olefins with active methylene compounds. (a) Reported literature; (b) This work.
Figure 2. Pd-catalyzed ring-opening of heterobicyclic olefins with active methylene compounds. (a) Reported literature; (b) This work.
Organics 04 00006 g002
Organics 04 00006 g003 550
Figure 3. Pd-catalyzed ring-opening of diazabicyclic olefin 1a with ethyl-4-chloro acetoacetate 2a.
Figure 3. Pd-catalyzed ring-opening of diazabicyclic olefin 1a with ethyl-4-chloro acetoacetate 2a.
Organics 04 00006 g003
Organics 04 00006 g004 550
Figure 4. Selected HMBC correlations of 3a.
Figure 4. Selected HMBC correlations of 3a.
Organics 04 00006 g004
Organics 04 00006 g005 550
Figure 5. Generality of 3(2H)-furanone-appended hydrazino cyclopentene synthesis from diazabicyclic olefins and of 4-halo-1,3-dicarbonyl compounds.
Figure 5. Generality of 3(2H)-furanone-appended hydrazino cyclopentene synthesis from diazabicyclic olefins and of 4-halo-1,3-dicarbonyl compounds.
Organics 04 00006 g005
Organics 04 00006 g006 550
Figure 6. Pd-catalyzed ring-opening of spirotricyclic olefin (4a) with ethyl-4-chloro acetoacetate (2a).
Figure 6. Pd-catalyzed ring-opening of spirotricyclic olefin (4a) with ethyl-4-chloro acetoacetate (2a).
Organics 04 00006 g006
Organics 04 00006 g007 550
Figure 7. Generality of 3(2H)-furanone-substituted hydrazino-spiro[2.4]hept-5-ene synthesis from diazabicyclic olefins and of 4-halo-1,3-dicarbonyl compounds.
Figure 7. Generality of 3(2H)-furanone-substituted hydrazino-spiro[2.4]hept-5-ene synthesis from diazabicyclic olefins and of 4-halo-1,3-dicarbonyl compounds.
Organics 04 00006 g007
Organics 04 00006 g008 550
Figure 8. Proposed mechanism for the Pd-catalyzed ring-opening of azabicyclic olefin with 4-halo acetoacetate.
Figure 8. Proposed mechanism for the Pd-catalyzed ring-opening of azabicyclic olefin with 4-halo acetoacetate.
Organics 04 00006 g008
Organics 04 00006 g009 550
Figure 9. Generality of amine-functionalized 3(2H)-furanone-appended hydrazino cyclopentene synthesis.
Figure 9. Generality of amine-functionalized 3(2H)-furanone-appended hydrazino cyclopentene synthesis.
Organics 04 00006 g009
Organics 04 00006 g010 550
Figure 10. Attempted intramolecular Heck coupling of amine-functionalized 3(2H)-furanone derivatives towards 3(2H)-furanone-fused tetrahydroazocine derivative.
Figure 10. Attempted intramolecular Heck coupling of amine-functionalized 3(2H)-furanone derivatives towards 3(2H)-furanone-fused tetrahydroazocine derivative.
Organics 04 00006 g010
Table
Table 1. Optimization studies.
Table 1. Optimization studies.
EntryCatalystLigandBaseSolventYield
1Pd(OAc)2dppfK2CO3THF10
2Pd(OCOCF3)2dppfK2CO3THF20
3Pd(PPh3)4dppfK2CO3THF15
4(Pd(allyl)Cl)2dppfK2CO3THF32
5PdCl2dppfK2CO3THF28
6Pd(dba)3.CHCl3dppfK2CO3THF23
7(Pd(allyl)Cl)2dppeK2CO3THF10
8(Pd(allyl)Cl)2dpppK2CO3THF34
9(Pd(allyl)Cl)2XPhosK2CO3THF55
10(Pd(allyl)Cl)2DevPhosK2CO3THF43
11(Pd(allyl)Cl)2XPhosNa2CO3THF51
12(Pd(allyl)Cl)2XPhosCs2CO3THF32
13(Pd(allyl)Cl)2XPhosNaHTHFNR
14(Pd(allyl)Cl)2XPhosNaOtBuTHF25
15(Pd(allyl)Cl)2XPhosK2CO3CH3CN68
16(Pd(allyl)Cl)2XPhosK2CO3Toluene47
17(Pd(allyl)Cl)2XPhosK2CO31,4-Dioane58
18(Pd(allyl)Cl)2XPhosK2CO3DCE85
Reaction conditions: 1a (1.0 equiv., 0.42 mmol), 2a (1.5 equiv., 0.62 mmol), base (2.0 equiv.), catalyst (5 mol%), ligand (10 mol%), solvent (2.0 mL), 60 °C, 12 h; isolated yields.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Omanakuttan, V.K.; Valsan, A.; Hopf, H.; John, J. Palladium Catalyzed Ring-Opening of Diazabicylic Olefins with 4-Halo-1,3-Dicarbonyl Compounds: Accessing 3(2H)-Furanone-Appended Cyclopentenes. Organics 2023, 4, 70-85. https://doi.org/10.3390/org4010006

AMA Style

Omanakuttan VK, Valsan A, Hopf H, John J. Palladium Catalyzed Ring-Opening of Diazabicylic Olefins with 4-Halo-1,3-Dicarbonyl Compounds: Accessing 3(2H)-Furanone-Appended Cyclopentenes. Organics. 2023; 4(1):70-85. https://doi.org/10.3390/org4010006

Chicago/Turabian Style

Omanakuttan, Vishnu K., Alisha Valsan, Henning Hopf, and Jubi John. 2023. "Palladium Catalyzed Ring-Opening of Diazabicylic Olefins with 4-Halo-1,3-Dicarbonyl Compounds: Accessing 3(2H)-Furanone-Appended Cyclopentenes" Organics 4, no. 1: 70-85. https://doi.org/10.3390/org4010006

Article Metrics

Back to TopTop